Dr. Hossain attended Brandeis University as a Wien Scholar and received his B.S. in Biology and Biochemistry. He earned his Ph.D. in Molecular Medicine from the University of Maryland under the Graduate Partnerships Program (GPP) with the National Institutes of Health (NIH). He completed his postdoctoral training at the Johns Hopkins University School of Medicine where he identified novel DNA-damaging polyphenols in foods and flavorings. He brings extensive knowledge of molecular, cancer and stem cell biology, epigenetics and immunology, as well as teaching experience as an Associate...Read more
Gilfranque Leite is Chemical Engineer, with MSc in Chemical Process Control and MBA in Project Management. 27 years of experience in Oil and Petrochemical Companies, with leadership rules in Operation, Process Engineering, Project and Capital Expenditure, Innovation and Technology. Since 2021 he leads the Global HES (Health, Safety and Environment) and Industrial Efficiency areas for Braskem.Read more
In 2009, Tom Foti co-founded Aldevron’s Protein Business Unit and currently serves in the role of Vice President / General Management. Aldevron’s Protein Business Unit offers development and manufacturing services to the research, diagnostic and therapeutic markets and is based in Madison, WI.
Tom has been instrumental in developing and launching the CRISPR product line at Aldevron. From off-the-shelf products to custom GMP manufacturing, he and his team has helped clients advance their programs from concept to the clinic. Tom has also been at the forefront of providing...Read more
Dr. Behlke directed R&D at IDT from 1995-2021. He is also a scientific co-founder of Dicerna Pharmaceuticals, in Boston. Before joining IDT, he was a Physician Postdoctoral Fellow of the Howard Hughes Medical Institute at the Whitehead Institute, MIT, and a Resident Physician in Internal Medicine at Brigham and Women’s Hospital. Dr. Behlke received his M.D/Ph.D. degrees from Washington University in 1988 and B.S. degree from MIT in 1981. Dr. Behlke is an inventor on over 65 issued US patents and is an author on over 150 scientific publications and book chapters. He is a recognized...Read more
Dr. Paul Diehl joined Cellecta, Inc. in July 2010 where he applies over two decades of experience in biotechnology to developing and expanding the company’s commercial and collaborative activities. Prior to joining Cellecta, Dr. Diehl held various marketing and business development positions at B-Bridge International, Agilent Technologies, Clontech Laboratories and other companies. Dr. Diehl received his B.A. in Biology from LaSalle University in Philadelphia, PA and his Ph.D. in Biochemistry from Washington State University in Pullman, WA.Read more
NEW YORK, NY — Bioengineers, scientists, and researchers invested in genome editing and the groundbreaking prospects afforded by CRISPR-based systems will share the latest intelligence in the field at the 5th International Conference on CRISPR...
